Global EPA & DHA Omega-3 Market Research Report 2021

Global EPA & DHA Omega-3 Market Research Report 2021

Report Code: KNJ780768 | No. of Pages: 132 | Category: Pharmaceuticals and Healthcare
Publisher: QYResearch | Date of Publish: Jun-2021
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
    Marine Animals Source Omega-3
    Marine Plant Source Omega-3

Segment by Application
    Dietary Supplements
    Fortified Food and Beverage
    Infant Formula
    Pharmaceuticals
    Pet Foods
    Others

By Region
    North America
        U.S.
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        Taiwan
        Indonesia
        Thailand
        Malaysia
        Philippines
        Vietnam
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

By Company
    DSM
    BASF
    EPAX
    Golden Omega
    TASA
    Omega Protein
    Croda
    Marine Ingredients
    GC Rieber
    Polaris
    Auqi
    Kinomega
    Skuny
    Xinzhou
    Anti-Cancer
    Sinomega
    Orkla Health
    LYSI
    OLVEA Fish Oils
    Hofseth BioCare
    Nippon Suisan Kaisha
    KD Pharma
    Shandong Yuwang Pharmaceutical
    Maruha Nichiro Foods
    Solutex
    Bioprocess Algae
1 EPA & DHA Omega-3 Market Overview
    1.1 Product Overview and Scope of EPA & DHA Omega-3
    1.2 EPA & DHA Omega-3 Segment by Type
        1.2.1 Global EPA & DHA Omega-3 Sales Growth Rate Comparison by Type (2021-2027)
        1.2.2 Marine Animals Source Omega-3
        1.2.3 Marine Plant Source Omega-3
    1.3 EPA & DHA Omega-3 Segment by Application
        1.3.1 EPA & DHA Omega-3 Sales Comparison by Application: (2021-2027)
        1.3.2 Dietary Supplements
        1.3.3 Fortified Food and Beverage
        1.3.4 Infant Formula
        1.3.5 Pharmaceuticals
        1.3.6 Pet Foods
        1.3.7 Others
    1.4 Global EPA & DHA Omega-3 Market Size Estimates and Forecasts
        1.4.1 Global EPA & DHA Omega-3 Revenue 2016-2027
        1.4.2 Global EPA & DHA Omega-3 Sales 2016-2027
        1.4.3 EPA & DHA Omega-3 Market Size by Region: 2016 Versus 2021 Versus 2027

2 EPA & DHA Omega-3 Market Competition by Manufacturers
    2.1 Global EPA & DHA Omega-3 Sales Market Share by Manufacturers (2016-2021)
    2.2 Global EPA & DHA Omega-3 Revenue Market Share by Manufacturers (2016-2021)
    2.3 Global EPA & DHA Omega-3 Average Price by Manufacturers (2016-2021)
    2.4 Manufacturers EPA & DHA Omega-3 Manufacturing Sites, Area Served, Product Type
    2.5 EPA & DHA Omega-3 Market Competitive Situation and Trends
        2.5.1 EPA & DHA Omega-3 Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest EPA & DHA Omega-3 Players Market Share by Revenue
        2.5.3 Global EPA & DHA Omega-3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 EPA & DHA Omega-3 Retrospective Market Scenario by Region
    3.1 Global EPA & DHA Omega-3 Retrospective Market Scenario in Revenue by Region: 2016-2021
    3.2 Global EPA & DHA Omega-3 Retrospective Market Scenario in Sales by Region: 2016-2021
    3.3 North America EPA & DHA Omega-3 Market Facts & Figures by Country
        3.3.1 North America EPA & DHA Omega-3 Sales by Country
        3.3.2 North America EPA & DHA Omega-3 Revenue by Country
        3.3.3 U.S.
        3.3.4 Canada
    3.4 Europe EPA & DHA Omega-3 Market Facts & Figures by Country
        3.4.1 Europe EPA & DHA Omega-3 Sales by Country
        3.4.2 Europe EPA & DHA Omega-3 Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific EPA & DHA Omega-3 Market Facts & Figures by Region
        3.5.1 Asia Pacific EPA & DHA Omega-3 Sales by Region
        3.5.2 Asia Pacific EPA & DHA Omega-3 Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
        3.5.12 Philippines
        3.5.13 Vietnam
    3.6 Latin America EPA & DHA Omega-3 Market Facts & Figures by Country
        3.6.1 Latin America EPA & DHA Omega-3 Sales by Country
        3.6.2 Latin America EPA & DHA Omega-3 Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa EPA & DHA Omega-3 Market Facts & Figures by Country
        3.7.1 Middle East and Africa EPA & DHA Omega-3 Sales by Country
        3.7.2 Middle East and Africa EPA & DHA Omega-3 Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global EPA & DHA Omega-3 Historic Market Analysis by Type
    4.1 Global EPA & DHA Omega-3 Sales Market Share by Type (2016-2021)
    4.2 Global EPA & DHA Omega-3 Revenue Market Share by Type (2016-2021)
    4.3 Global EPA & DHA Omega-3 Price by Type (2016-2021)

5 Global EPA & DHA Omega-3 Historic Market Analysis by Application
    5.1 Global EPA & DHA Omega-3 Sales Market Share by Application (2016-2021)
    5.2 Global EPA & DHA Omega-3 Revenue Market Share by Application (2016-2021)
    5.3 Global EPA & DHA Omega-3 Price by Application (2016-2021)

6 Key Companies Profiled
    6.1 DSM
        6.1.1 DSM Corporation Information
        6.1.2 DSM Description and Business Overview
        6.1.3 DSM EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2016-2021)
        6.1.4 DSM Product Portfolio
        6.1.5 DSM Recent Developments/Updates
    6.2 BASF
        6.2.1 BASF Corporation Information
        6.2.2 BASF Description and Business Overview
        6.2.3 BASF EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2016-2021)
        6.2.4 BASF Product Portfolio
        6.2.5 BASF Recent Developments/Updates
    6.3 EPAX
        6.3.1 EPAX Corporation Information
        6.3.2 EPAX Description and Business Overview
        6.3.3 EPAX EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2016-2021)
        6.3.4 EPAX Product Portfolio
        6.3.5 EPAX Recent Developments/Updates
    6.4 Golden Omega
        6.4.1 Golden Omega Corporation Information
        6.4.2 Golden Omega Description and Business Overview
        6.4.3 Golden Omega EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2016-2021)
        6.4.4 Golden Omega Product Portfolio
        6.4.5 Golden Omega Recent Developments/Updates
    6.5 TASA
        6.5.1 TASA Corporation Information
        6.5.2 TASA Description and Business Overview
        6.5.3 TASA EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2016-2021)
        6.5.4 TASA Product Portfolio
        6.5.5 TASA Recent Developments/Updates
    6.6 Omega Protein
        6.6.1 Omega Protein Corporation Information
        6.6.2 Omega Protein Description and Business Overview
        6.6.3 Omega Protein EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2016-2021)
        6.6.4 Omega Protein Product Portfolio
        6.6.5 Omega Protein Recent Developments/Updates
    6.7 Croda
        6.6.1 Croda Corporation Information
        6.6.2 Croda Description and Business Overview
        6.6.3 Croda EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2016-2021)
        6.4.4 Croda Product Portfolio
        6.7.5 Croda Recent Developments/Updates
    6.8 Marine Ingredients
        6.8.1 Marine Ingredients Corporation Information
        6.8.2 Marine Ingredients Description and Business Overview
        6.8.3 Marine Ingredients EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2016-2021)
        6.8.4 Marine Ingredients Product Portfolio
        6.8.5 Marine Ingredients Recent Developments/Updates
    6.9 GC Rieber
        6.9.1 GC Rieber Corporation Information
        6.9.2 GC Rieber Description and Business Overview
        6.9.3 GC Rieber EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2016-2021)
        6.9.4 GC Rieber Product Portfolio
        6.9.5 GC Rieber Recent Developments/Updates
    6.10 Polaris
        6.10.1 Polaris Corporation Information
        6.10.2 Polaris Description and Business Overview
        6.10.3 Polaris EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2016-2021)
        6.10.4 Polaris Product Portfolio
        6.10.5 Polaris Recent Developments/Updates
    6.11 Auqi
        6.11.1 Auqi Corporation Information
        6.11.2 Auqi EPA & DHA Omega-3 Description and Business Overview
        6.11.3 Auqi EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2016-2021)
        6.11.4 Auqi Product Portfolio
        6.11.5 Auqi Recent Developments/Updates
    6.12 Kinomega
        6.12.1 Kinomega Corporation Information
        6.12.2 Kinomega EPA & DHA Omega-3 Description and Business Overview
        6.12.3 Kinomega EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2016-2021)
        6.12.4 Kinomega Product Portfolio
        6.12.5 Kinomega Recent Developments/Updates
    6.13 Skuny
        6.13.1 Skuny Corporation Information
        6.13.2 Skuny EPA & DHA Omega-3 Description and Business Overview
        6.13.3 Skuny EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2016-2021)
        6.13.4 Skuny Product Portfolio
        6.13.5 Skuny Recent Developments/Updates
    6.14 Xinzhou
        6.14.1 Xinzhou Corporation Information
        6.14.2 Xinzhou EPA & DHA Omega-3 Description and Business Overview
        6.14.3 Xinzhou EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2016-2021)
        6.14.4 Xinzhou Product Portfolio
        6.14.5 Xinzhou Recent Developments/Updates
    6.15 Anti-Cancer
        6.15.1 Anti-Cancer Corporation Information
        6.15.2 Anti-Cancer EPA & DHA Omega-3 Description and Business Overview
        6.15.3 Anti-Cancer EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2016-2021)
        6.15.4 Anti-Cancer Product Portfolio
        6.15.5 Anti-Cancer Recent Developments/Updates
    6.16 Sinomega
        6.16.1 Sinomega Corporation Information
        6.16.2 Sinomega EPA & DHA Omega-3 Description and Business Overview
        6.16.3 Sinomega EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2016-2021)
        6.16.4 Sinomega Product Portfolio
        6.16.5 Sinomega Recent Developments/Updates
    6.17 Orkla Health
        6.17.1 Orkla Health Corporation Information
        6.17.2 Orkla Health EPA & DHA Omega-3 Description and Business Overview
        6.17.3 Orkla Health EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2016-2021)
        6.17.4 Orkla Health Product Portfolio
        6.17.5 Orkla Health Recent Developments/Updates
    6.18 LYSI
        6.18.1 LYSI Corporation Information
        6.18.2 LYSI EPA & DHA Omega-3 Description and Business Overview
        6.18.3 LYSI EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2016-2021)
        6.18.4 LYSI Product Portfolio
        6.18.5 LYSI Recent Developments/Updates
    6.19 OLVEA Fish Oils
        6.19.1 OLVEA Fish Oils Corporation Information
        6.19.2 OLVEA Fish Oils EPA & DHA Omega-3 Description and Business Overview
        6.19.3 OLVEA Fish Oils EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2016-2021)
        6.19.4 OLVEA Fish Oils Product Portfolio
        6.19.5 OLVEA Fish Oils Recent Developments/Updates
    6.20 Hofseth BioCare
        6.20.1 Hofseth BioCare Corporation Information
        6.20.2 Hofseth BioCare EPA & DHA Omega-3 Description and Business Overview
        6.20.3 Hofseth BioCare EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2016-2021)
        6.20.4 Hofseth BioCare Product Portfolio
        6.20.5 Hofseth BioCare Recent Developments/Updates
    6.21 Nippon Suisan Kaisha
        6.21.1 Nippon Suisan Kaisha Corporation Information
        6.21.2 Nippon Suisan Kaisha EPA & DHA Omega-3 Description and Business Overview
        6.21.3 Nippon Suisan Kaisha EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2016-2021)
        6.21.4 Nippon Suisan Kaisha Product Portfolio
        6.21.5 Nippon Suisan Kaisha Recent Developments/Updates
    6.22 KD Pharma
        6.22.1 KD Pharma Corporation Information
        6.22.2 KD Pharma EPA & DHA Omega-3 Description and Business Overview
        6.22.3 KD Pharma EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2016-2021)
        6.22.4 KD Pharma Product Portfolio
        6.22.5 KD Pharma Recent Developments/Updates
    6.23 Shandong Yuwang Pharmaceutical
        6.23.1 Shandong Yuwang Pharmaceutical Corporation Information
        6.23.2 Shandong Yuwang Pharmaceutical EPA & DHA Omega-3 Description and Business Overview
        6.23.3 Shandong Yuwang Pharmaceutical EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2016-2021)
        6.23.4 Shandong Yuwang Pharmaceutical Product Portfolio
        6.23.5 Shandong Yuwang Pharmaceutical Recent Developments/Updates
    6.24 Maruha Nichiro Foods
        6.24.1 Maruha Nichiro Foods Corporation Information
        6.24.2 Maruha Nichiro Foods EPA & DHA Omega-3 Description and Business Overview
        6.24.3 Maruha Nichiro Foods EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2016-2021)
        6.24.4 Maruha Nichiro Foods Product Portfolio
        6.24.5 Maruha Nichiro Foods Recent Developments/Updates
    6.25 Solutex
        6.25.1 Solutex Corporation Information
        6.25.2 Solutex EPA & DHA Omega-3 Description and Business Overview
        6.25.3 Solutex EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2016-2021)
        6.25.4 Solutex Product Portfolio
        6.25.5 Solutex Recent Developments/Updates
    6.26 Bioprocess Algae
        6.26.1 Bioprocess Algae Corporation Information
        6.26.2 Bioprocess Algae EPA & DHA Omega-3 Description and Business Overview
        6.26.3 Bioprocess Algae EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2016-2021)
        6.26.4 Bioprocess Algae Product Portfolio
        6.26.5 Bioprocess Algae Recent Developments/Updates

7 EPA & DHA Omega-3 Manufacturing Cost Analysis
    7.1 EPA & DHA Omega-3 Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of EPA & DHA Omega-3
    7.4 EPA & DHA Omega-3 Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 EPA & DHA Omega-3 Distributors List
    8.3 EPA & DHA Omega-3 Customers

9 EPA & DHA Omega-3 Market Dynamics
    9.1 EPA & DHA Omega-3 Industry Trends
    9.2 EPA & DHA Omega-3 Growth Drivers
    9.3 EPA & DHA Omega-3 Market Challenges
    9.4 EPA & DHA Omega-3 Market Restraints

10 Global Market Forecast
    10.1 EPA & DHA Omega-3 Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of EPA & DHA Omega-3 by Type (2022-2027)
        10.1.2 Global Forecasted Revenue of EPA & DHA Omega-3 by Type (2022-2027)
    10.2 EPA & DHA Omega-3 Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of EPA & DHA Omega-3 by Application (2022-2027)
        10.2.2 Global Forecasted Revenue of EPA & DHA Omega-3 by Application (2022-2027)
    10.3 EPA & DHA Omega-3 Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of EPA & DHA Omega-3 by Region (2022-2027)
        10.3.2 Global Forecasted Revenue of EPA & DHA Omega-3 by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com